Methods of assessing HIV integrase inhibitor therapy

Details Methods of assessing HIV integrase inhibitor therapy Methods of assessing HIV integrase inhibitor therapy

2005-10-25

2005-10-25

Guzo, David (Department: 1636)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C435S006120, C435S007100, C435S091100, C435S091200, C435S091210, C435S091300, C435S091320, C435S091330, C536S023100, C536S024300, C536S024330

Reexamination Certificate

active

06958211

ABSTRACT:
Methods and products for the evaluation of HIV treatment are provided. The methods are based on evaluating molecular events at the HIV integrase resulting in altered therapeutic efficacy of tho investigated compounds. The methods rely on providing an integrase gene and evaluating either through integrase gene genotyping or phenotyping.

REFERENCES:
patent: 5202259 (1993-04-01), Goff et al.
patent: 6221578 (2001-04-01), de Bethune et al.
patent: 6562575 (2003-05-01), Dahl
patent: 6635472 (2003-10-01), Lauermann
patent: WO 94/16737 (1994-08-01), None
patent: WO 99/40227 (1999-08-01), None
patent: WO 99/67427 (1999-12-01), None
patent: WO 01/16860 (2001-03-01), None
patent: WO 01/57245 (2001-08-01), None
patent: WO 01/79540 (2001-10-01), None
patent: WO 02/23186 (2002-03-01), None
patent: WO 02/33402 (2002-04-01), None
Beorud, C. et al., “UMD (Universal Mutation Database): A generic Software to Build and Analyze Locus-Specific Databases”,Human Mutation, Jan. 2000, 15(1), 86-94.
Boom, R. et al., “Rapid and Simple Method for Purification of Nucleic Acids”,Journal of Clinical Microbiology, 1990, 28(3), 495-503.
De Leon, et al. “Clinical Feature . . . ”,Italian Journal of Gastroenterology and Hepatology, Dec. 1999, 31(9), 850-860.
Harrigan, P.R.et al., “Baseline HIV Drug Resistance Profile Predicts Response to Ritonavir-Saquinavir Protease Inhibitor Therapy in a Community Settings”,AIDS, 1999, 13, 1863-1871.
Hazuda, D.J. et al., “Inhibitors of Strand Transfer that Prevent Integration and Inhibit HIV-1 Replication in Cells”,Science, 2000, 287, 645-650.
Hertogs, et al., “Comprehensive HIV Drug Resistance Monitoring Using Rapid, High-Throughput Phenotypic and Genotypic Assays with Correlative Data Analysis”,AIDS, 1998, 12, Poster Abstracts OP3.4, ppS 11.
Hertogs, K. et al., “A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs”Antimicrobial Agents and Chemotherapy, 1998, 42(2), 269-276.
Jean pierre Cecile, et al., “Software and Database for the Analysis of Mutations in the Human WT1 Gene”Nucleic Acids Research, Jan. 1998, 26(1), 271-274.
Kellem, P. et al., “Recombinant Virus Assay: A Rapid, Pheotypic Assay for Assessment of Drug Susceptibility of Human Immunodeficiency virus Type 1 Isolates”,Antimicrobial Agents and Chemotherapy, 1994, 38, 23-30.
Larder, B. et al., “A Complete Survey in Over 1,500 Clinical HIV-1 Isolates, of Phenotypic and Genotypic Protease Inhibitor Resistance Profiles (Including GAG Cleavage Site Sequences and Their Relation to Therapy History”,AIDS, 1998, 12(4), S11.
Laurent-Puig Pierre, et al.,“APC Gene: Database of Germline and Somatic Mutations in Human Tumors and Cell Lines”,Nucleic Acids Research, 1998, 26(1), 269-270.
Pauwels, R. et al., “Correlation Between Genotypic and Phenotypic Resistance Data in Avanti”,Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotheraphy, 1997, 37, 263-264.
Pauwels, R. et al., “Rapid and Automated Tetrazolium-Based Colorimetric Assay for the Detection of Anti-HIV Compounds”Journal of Virological Methods, 1988, 20, 309-321.
Petropoulos, C,J, et al., “Human Immunodeficiency Virus 1, Complete Genome”Database Genbank NCBI, 2000, Accession nr. NC_001802.
Vandamme, et al., “Managing Resistance to Anti-HIV Drugs-AN Important Consideration for Effective Disease Management”,Drugs, 1999, 57(3), 337-361.
Water, H. et al., “Rapid, Phenotypic HIV-1 Drug Sensitivity Assay for Protease and Reverse Transcriptase Inhibitors”,Journal of Clinical Virolology, 1999, 13, 71-80.
Wegner, S.A.et al.,“Prevalence of Genotypic and Phenotypic esistance to Anti-Retroviral Drugs in a Cohort of Therapy-Naïve HIV-1 Infected US Military Personnel”,AIDS, 2000, 14, 1009-1015.
Woerner, A.M. et al., “Characterization of a DNA Binding Domain in the C-Terminus of HIV-1 Integrase by Deletion Mutagenesis”,Nucleic Acids Research, 1993, 21(15), 3507-3511.
Ryan Reinke, et al., “Natural Selection Results in Conservation of HIV-1 Integrase Activity Despite Sequence Variability”, AIDS 2001, vol. 15, No. 7, 2001, pp. 823-830.
Peter J. King, et al., “Resistance to the Anti-Human Immunodeficiency Virus Type 1 Compound L-Chicoric Acid Results from a Single Mutation at Amino Acid 140 of Integrase”, Journal of Virology, vol. 72, No. 10, 1998, pp. 8420-8424.
NCBI Sequence Viewer Search of Nucleotide, Human Immunodeficiency virus 1, pp. 1-7, downloaded Nov. 19, 2002.
Martin S. Hirsch, et al., “Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection”, Consensus Statement, JAMA., vol. 283, No. 18, 2000, pp. 2417-2426.
A-M VanDamme, et al., “Laboratory Guidelines for the Practical Use of HIV Drug Resistance Tests in Patient Follow-Up”, 2001, Antiviral Therapy, vol. 6, No. 21, pp. 21-39.
Lynn M. Skinner, et al., “Analysis of a Large Collection of Natural HIV-1 Integrase Sequences, Including Those From Long-Term Nonprogressors”, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 19, No. 2, 1998, pp 99-110.

Affiliated with

Also associated with

Rating

Methods of assessing HIV integrase inhibitor therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of assessing HIV integrase inhibitor therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of assessing HIV integrase inhibitor therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3437800